You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,494,654

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 7,494,654

Title:	Compositions and methods for treating cardiovascular conditions with botulinum toxin
Abstract:	The present invention provides for methods of treating cardiovascular diseases in a mammal. The methods include a step of administering an effective amount of a botulinum toxin directly to a blood vessel of a mammal thereby treating a cardiovascular disease.
Inventor(s):	Brooks; Gregory F. (Irvine, CA), Donovan; Stephen (Capistrano Beach, CA)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	10/870,603
Patent Claims:	1. A method for treating coronary arterial blockage in a mammal the method comprising the steps of (a) administering an effective amount of a botulinum toxin directly to a wall of a blood vessel of a mammal in an area of the coronary arterial blockage (b) allowing the blood vessel to dilate (c) inserting a balloon catheter and a stent coated or impregnated with a botulinum toxin into a femoral artery, (d) passing the balloon catheter and stent to the area of the coronary arterial blockage, (e) inflating the balloon catheter, and (f) expanding the stent to brace open the blood vessel, thereby treating the coronary arterial blockage. 2. The method of claim 1 wherein treating the coronary arterial blockage prevents restenosis. 3. The method of claim 1 wherein the botulinum toxin is selected from the group consisting of botulinum toxin type A, botulinum toxin type B, botulinum toxin type C, botulinum toxin type D, botulinum toxin type E, botulinum toxin type F and botulinum toxin type G, mixtures thereof and combinations thereof. 4. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type A. 5. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type B. 6. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type C. 7. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type D. 8. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type E. 9. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type F. 10. The method of claim 1 wherein the botulinum toxin comprises botulinum toxin type G.

Details for Patent 7,494,654

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Solstice Neurosciences, Llc	MYOBLOC	rimabotulinumtoxinb	Injection	103846	12/08/2000	⤷ Try a Trial	2019-08-10
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.